Gene · 6329
Papers1,928
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,928
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Somatic Mutation Trajectories Define Prognostically Distinct Subtypes and Shape the Tumor Microenvironment in Gastric Cancer. | Genes (Basel) | 2026 | 42194993 | PubTator, text mining | PubMed |
| Targeting Arrhythmogenic Late Sodium Current by FHF1A-Derivative FixR in Heart Failure Cardiomyocytes. | Circ Res | 2026 | 42186805 | PubTator, text mining | PubMed |
| Trio Whole-Genome Sequencing for Diagnosis of Neonates with Multiple Congenital Anomalies. | Neonatology | 2026 | 42139173 | PubTator, text mining | PubMed |
| Flecainide binding dynamics in voltage-gated sodium channels: A comparative isoform analysis of the state-dependent block. | Br J Pharmacol | 2026 | 42026409 | PubTator, text mining | PubMed |
| Hypokalemic periodic paralysis: novel perspectives from genetic mutations to clinical management. | Gene | 2026 | 42013926 | PubTator, text mining | PubMed |
| Missense mutation causes multiple defects in Nav1.4 channel gating and leads to an SCN4A-associated overlap phenotype. | J Gen Physiol | 2026 | 42012473 | PubTator, text mining | PubMed |
| Design, Synthesis, and Structure-Activity Relationship Study of μ-Conotoxin KIIIA toward NaV1.4. | J Med Chem | 2026 | 41913656 | PubTator, text mining | PubMed |
| Clinical features and advances in the genetics of periodic paralysis. | PeerJ | 2026 | 41800133 | PubTator, text mining | PubMed |
| Osteoarthritis: molecular pathogenesis and potential therapeutic options. | Signal Transduct Target Ther | 2026 | 41781374 | PubTator, text mining | PubMed |
| The Cardioprotective Potential of Marine Venom and Toxins. | Toxins (Basel) | 2026 | 41745729 | PubTator, text mining | PubMed |
| Exceptionally selective voltage-sensor trapping of NaV1.5 channels by Mg-protoporphyrin impairs cancer cell migration. | Sci Rep | 2026 | 41611918 | PubTator, text mining | PubMed |
| Hypokalemic Periodic Paralysis Associated With a Rare CACNA1S Variant (p.Leu1243Val): Expanding the Mutational Spectrum. | Case Rep Genet | 2026 | 41551049 | PubTator, text mining | PubMed |
| Inhibition of human Nav1.4 by D-amino acid modified μ-CnIIIC. | Bioorg Chem | 2026 | 41520619 | PubTator, text mining | PubMed |
| [Functional analysis of the mutant channels associated with skeletal muscle channelopathies]. | Nihon Yakurigaku Zasshi | 2026 | 41485931 | PubTator, text mining | PubMed |
| Piper rhythm-like electromyographical activity in muscle stiffness in sodium channel myotonia representing potassium-aggravated myotonia and myotonia permanens. | J Neurophysiol | 2026 | 41442183 | PubTator, text mining | PubMed |
| Synergistic DBNDD1-GDF15 Signaling Activates the NF-κB Pathway to Promote Colorectal Cancer Progression. | Mol Cancer Res | 2026 | 41182793 | PubTator, text mining | PubMed |
| Gene expression, purification, and functional characterization of recombinant conotoxin μ-TIIIA and TIIIAlaMut in Escherichia coli with clinical evaluation of antiwrinkle efficacy. | BioTechnologia (Pozn) | 2025 | 41613856 | PubTator, text mining | PubMed |
| Thyrotoxic Hypokalemic Periodic Paralysis: Pathophysiological Mechanisms. | Endocrinol Metab (Seoul) | 2025 | 41376301 | PubTator, text mining | PubMed |
| Development and validation of a machine learning-based prognostic model using mitochondrial dysfunction-related genes for colorectal cancer patients. | Transl Cancer Res | 2025 | 41234872 | PubTator, text mining | PubMed |
| Long term safety and efficacy of lamotrigine in patients with non-dystrophic myotonia, a single-centre prospective study. | Neuromuscul Disord | 2025 | 41202340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6329/papers?page=2